Two-dimensional Structure of Beta-amyloid(10-35) Fibrils
Overview
Affiliations
Beta-amyloid (Abeta) peptides are the main protein component of the pathognomonic plaques found in the brains of patients with Alzheimer's disease. These heterogeneous peptides adopt a highly organized fibril structure both in vivo and in vitro. Here we use solid-state NMR on stable, homogeneous fibrils of Abeta(10-35). Specific interpeptide distance constraints are determined with dipolar recoupling NMR on fibrils prepared from a series of singly labeled peptides containing (13)C-carbonyl-enriched amino acids, and skipping no more that three residues in the sequence. From these studies, we demonstrate that the peptide adopts the structure of an extended parallel beta-sheet in-register at pH 7.4. Analysis of DRAWS data indicates interstrand distances of 5.3 +/- 0.3 A (mean +/- standard deviation) throughout the entire length of the peptide, which is compatible only with a parallel beta-strand in-register. Intrastrand NMR constraints, obtained from peptides containing labels at two adjacent amino acids, confirm the secondary structural findings obtained using DRAWS. Using peptides with (13)C incorporated at the carbonyl position of adjacent amino acids, structural transitions from alpha-helix to beta-sheet were observed at residues 19 and 20, but using similar techniques, no evidence for a turn could be found in the putative turn region comprising residues 25-29. Implications of this extended parallel organization for Abeta(10-35) for overall fibril formation, stability, and morphology based upon specific amino acid contacts are discussed.
Mocanu C, Niculaua M, Zbancioc G, Mangalagiu V, Drochioiu G Int J Mol Sci. 2022; 23(5).
PMID: 35269999 PMC: 8911100. DOI: 10.3390/ijms23052857.
Interpenetrating Cubes in the X-ray Crystallographic Structure of a Peptide Derived from Medin.
Howitz W, Wierzbicki M, Cabanela R, Saliba C, Motavalli A, Tran N J Am Chem Soc. 2020; 142(37):15870-15875.
PMID: 32816461 PMC: 7819122. DOI: 10.1021/jacs.0c06143.
Fibrillar and Nonfibrillar Amyloid Beta Structures Drive Two Modes of Membrane-Mediated Toxicity.
Vander Zanden C, Wampler L, Bowers I, Watkins E, Majewski J, Chi E Langmuir. 2019; 35(48):16024-16036.
PMID: 31509701 PMC: 7385729. DOI: 10.1021/acs.langmuir.9b02484.
Wang S, Lin Y, Spencer R, Thomas M, Nguyen A, Amdursky N ACS Nano. 2017; 11(9):8579-8589.
PMID: 28771324 PMC: 5618150. DOI: 10.1021/acsnano.7b02325.
Amyloid beta: structure, biology and structure-based therapeutic development.
Chen G, Xu T, Yan Y, Zhou Y, Jiang Y, Melcher K Acta Pharmacol Sin. 2017; 38(9):1205-1235.
PMID: 28713158 PMC: 5589967. DOI: 10.1038/aps.2017.28.